Stem cell therapy: Hope or hype?

British Medical Journal

Volumn 330, Issue 7501, 2005, Pages 1159-1160

  Braude, Peter ^a   Minger, Stephen L ^a   Warwick, Ruth M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; COMMERCIAL PHENOMENA; DEGENERATIVE DISEASE; DONOR; EDITORIAL; GENE THERAPY; HEMOPHILIA; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; SAFETY; STEM CELL TRANSPLANTATION; TECHNOLOGY; VIRUS TRANSMISSION;

EID: 19744379343     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7501.1159     Document Type: Editorial

References (11)

1. Select Committee of the House of Lords. Stem cell research-report. London: Stationery Office, 2002. www.parliament.the-stationery-office.co.uk/pa/ ld200102/ldselect/ldstem/83/8301.htm (accessed 13 May 2005).
2. Medicines and Healthcare products Regulatory Agency. Rules and guidance for pharmaceutical manufacturers and distributors. London: Department of Health, 1997. http://medicines.mhra.gov.uk/inforesources/ publications/orangeguide.htm (accessed 13 May 2005).
3. Centers for Disease Control and Prevention. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft-Spain 1985-1992. Morb Mortal Wkly Rep MMWR 1993;42:560-3. http://www.cdc.gov/ mmwr/preview/mmwrhtml/00021225. htm
4. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
5. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004;364:527-9.
6. Department of Health. A code of practice for tissue banks providing tissues of human origin for therapeutic purposes. 2001. www.dh.gov.uk/ Publications AndStatistics/Publications/PublicationsPolicyAndGuidance/ Publications PolicyAndGuidanceArticle/fs/en?CONTENT_ID = 4006116&chk=8VQ R%2B5
7. Directive 2004/23/EC of the European Communities and of the Council of 31 March 2004 on setting standards of quality and safely for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official J Eur Onion 2004. http:// europa.cu.int/eur- lex/pri/en/oj/dat/2004/1_102/1_10220040407en00 480058.pdf (accessed 13 May 2005).
8. Jayarama KS. Indian regulations fail to monitor growing stem-cell use in clinics. Nature 2005, March 17:434,259.
9. Danilova, M. Stem cell craze spreads in Russia. Associated Press: http://apnews.myway.com/article/20050314/D88QNPG80.html
10. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 2004;44:1690-9.
11. Rifkin J. Are you a man or a mouse? Guardian 2004, 15 March. www.guardian.co.uk/comment/story/0,1437701,00.html (accessed 13 May 2005).